We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
CN Bio Logo

CN Bio

CN Bio is a close-knit team of passionate scientists, engineers and creative thinkers, all working together towards a shared goal – a future where drugs are discovered more quickly, brought to patients more cost-effectively and with less animal experimentation. Day to day, their cohesive team design, manufacture, promote and support organ-on-a-chip solutions that enable their customers to do something incredible – recreate three-dimensional human organs and tissues in the laboratory to improve understanding of human physiology, disease and the effectiveness of new drugs.

Latest Content

Molecular structure emerging between blue and red capsules, symbolizing modern drug discovery.
Product News

CN Bio Launches All-in-One Organ-on-a-Chip System, PhysioMimix® Core

CN Bio launches PhysioMimix Core, the first all-in-one organ-on-a-chip system for scalable, multi-organ drug discovery.
Digital model of a human liver glowing on a dark blue background.
Article

The Future of Liver Health: Can Human Models and Machine Learning Reduce Disease Rates?

Explore how new innovations are bringing fresh hope for the future of liver health in the form of predictive, human-relevant research tools that can be used to understand disease and accelerate the development of novel therapies.
Scientists in a laboratory analyzing computer data for drug discovery research.
Product News

CN Bio Adds Computational Modeling Capabilities to ADME Services for Enhanced Bioavailability Profiling

CN Bio expands its research services with new in silico tools to improve ADME profiling and drug discovery translation.
3D rendering of an organ-on-a-chip model with interconnected channels for biomedical research.
Product News

CN Bio Introduces Cross-Species DILI Services To Enhance In Vitro to In Vivo Extrapolation During Preclinical Drug Development

CN Bio introduces new animal MPS models to improve drug safety and predict human toxicity in preclinical drug testing.
Female scientist in lab examining a sample vial with focus and concentration.
Product News

CN Bio Expands Access to OOC Solutions for APAC Customers With Distributor Agreement in South Korea

CN Bio partners with SCINCO to expand its reach in South Korea, enhancing access to its FDA-recognized PhysioMimix® Organ-on-a-chip systems.
Two transparent organ-on-a-chip devices with red and blue microfluidic channels simulating biological systems.
Product News

CN Bio and Pharmaron Establish Long-Term Strategic Partnership To Develop OOC Technologies on a Global R&D Platform

CN Bio and Pharmaron have partnered to validate PhysioMimix® OOC technology, aiming to improve drug discovery and development through human-relevant models.
Cells.
Product News

CN Bio Launches PhysioMimix DILI Assay Kit: Human 24, for Enhanced Preclinical Toxicology Testing

CN Bio, announced the launch of its PhysioMimix® DILI assay kit: Human 24. Built upon CN Bio’s human-derived and highly characterized liver microphysiological system (MPS).
Cells.
Product News

CN Bio Signs Strategic Partnership With Primetech Corporation To Establish Distribution Channel for OOC Solutions in Japan

CN Bio, announced it has entered into a strategic partnership with Japanese life sciences research equipment distributor, Primetech.
Drug discovery.
Product News

CN Bio Launches PhysioMimix Bioavailability Assay Kit: Human 18

CN Bio, announced the launch of its PhysioMimix® Bioavailability assay kit: Human 18. Harnessing the capabilities of the PhysioMimix Multi-organ System, the kit enhances lead optimization and preclinical testing pipelines.
White outline of a human liver and blood vessels on a woman wearing a grey t-shirt.
Article

A Reflection on Global Fatty Liver Day 2024: How Organ-on-a-Chip Addresses R&D Challenges

To commemorate Global Fatty Liver Day, this article explores how organ-on-a-chip models are transforming liver disease research.
Advertisement